跳到正文
原文
Journal of Clinical Oncology 临床肿瘤· Sara M. Federico·· 14 天前AI 评分25

高危神经母细胞瘤诱导治疗期间化疗免疫疗法可行性与耐受性报告

Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology Group

AI 导读

该报告来自儿童肿瘤组,探讨了高危神经母细胞瘤患者在诱导治疗期间接受化疗免疫疗法的可行性和耐受性。

来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org